Your SlideShare is downloading. ×
UK Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

UK Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities

94
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
94
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. UK Microbiology Testing Market: Innovative Technologies andEmerging Business OpportunitiesReport Details:Published:December 2012No. of Pages: 978Price: Single User License – US$5900Highlights•Comprehensive 978-page analysis of the UK microbiology testing market.•Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.•Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in UK hospitals, blood banks, public health and commercial laboratories.•Instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Get your copy of this report @http://www.reportsnreports.com/reports/210778-uk-microbiology-testing-market-innovative-technologies-and-emerging-business-opportunities.htmlMajor points covered in Table of Contents of this report includeTable of ContentsIntroductionWorldwide Market and Technology OverviewA. Major Infectious Disease Tests1. AIDSa. Background
  • 2. b. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Tests0 Identification from Culturec. Vaccines and Drugs11. Candidaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 3. 12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs15. Clostridium Difficilea. Backgroundb. Diagnostic Testsc. Drugs and Vaccines16. Coronavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs17. Coxsackievirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs18. Creutzfeldt-Jakob’s Diseasea. Backgroundb. Diagnostic Testsc. Vaccines19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs22. Ebola Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 4. 23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs24. EchoVirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs25. Encephalitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs26. Enterovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs27. Epstein-Barr Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs28. Giardia Lambliaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs32. Helicobacter Pyloria. Backgroundb. Diagnostic Testsc. Vaccines and Drugs33. Hepatitisa. Background
  • 5. b. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines and Drugs34. Herpes Simplex Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs35. Human Herpes Virus-6 (HHV-6)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs42. Meningitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs43. Microsporidiuma. Background
  • 6. b. Diagnostic Testsc. Vaccines and Drugs44. Mononucleosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs46. Mycoplasmaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs53. Respiratory Syncytial Virus (RSV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs
  • 7. 54. RhinoVirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs55. RotaVirus (REOVIRUS)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs56. Rubella(MEASLES)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs57. Salmonellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs58. Septicemiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs59. Shigellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs60. Staphylococcus Aureusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs61. Streptococcia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs62. Syphilisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs63. Toxoplasmosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs64. Trichomonas Vaginalisa. Background
  • 8. b. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs68. Yersinaa. Backgroundb. Diagnostic Testsc. Vaccines and DrugsB. Instrumentation Review of Leading Analyzers Marketed by Abbott, BeckmanCoulter/Danaher, BioMerieux,Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,Wallacand Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherUKA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/Panels
  • 9. C. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for DecentralizedTesting Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive AssessmentsAbbottAffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatech
  • 10. Life TechnologyLonzaNanogen/ElitechNovartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenomSeraCareSiemensTakara BioThermo FisherWallacWakoList of TablesMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Adenovirus TestsMajor Companies Developing or Marketing Bartonella TestsMajor Companies Developing or Marketing Campylobacter TestsMajor Companies Developing or Marketing Candida TestsMajor Companies Developing or Marketing Chlamydia TestsMajor Companies Developing or Marketing Clostridium TestsMajor Companies Developing or Marketing Coronavirus TestsMajor Companies Developing or Marketing Cryptosporidium TestsMajor Companies Developing or Marketing CMV TestsMajor Companies Developing or Marketing Echovirus TestsMajor Companies Developing or Marketing Enterovirus TestsMajor Companies Developing or Marketing EBV TestsMajor Companies Developing or Marketing Giardia TestsMajor Companies Developing or Marketing Gonorrhea TestsMajor Companies Developing or Marketing Hantavirus TestsMajor Companies Developing or Marketing Helicobacter Pylori TestsMajor Companies Developing or Marketing Hepatitis TestsMajor Companies Developing or Marketing Herpes TestsMajor Companies Developing or Marketing Influenza TestsMajor Companies Developing or Marketing Legionella TestsMajor Companies Developing or Marketing Lyme Disease TestsMajor Companies Developing or Marketing Lymphogranuloma TestsMajor Companies Developing or Marketing Malaria TestsMajor Companies Developing or Marketing Measles TestsMajor Companies Developing or Marketing Meningitis Tests
  • 11. Major Companies Developing or Marketing Microsporidium TestsMajor Companies Developing or Marketing Mononucleosis TestsMajor Companies Developing or Marketing Mumps TestsMajor Companies Developing or Marketing Mycoplasma TestsMajor Companies Developing or Marketing Papilloma Virus TestsMajor Companies Developing or Marketing Parvovirus TestsMajor Companies Developing or Marketing Pneumonia TestsMajor Companies Developing or Marketing RSV TestsMajor Companies Developing or Marketing Rotavirus TestsMajor Companies Developing or Marketing Rubella TestsMajor Companies Developing or Marketing Salmonella TestsMajor Companies Developing or Marketing Septicemia TestsMajor Companies Developing or Marketing Shigella TestsMajor Companies Developing or Marketing Staphylococci TestsMajor Companies Developing or Marketing Streptococci TestsMajor Companies Developing or Marketing Syphilis TestsMajor Companies Developing or Marketing Toxoplasmosis TestsMajor Companies Developing or Marketing Trichomonas TestsMajor Companies Developing or Marketing Tuberculosis TestsMajor Companies Developing or Marketing West Nile TestsMajor Companies Developing or Marketing Yersinia TestsUK Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast byMarket SegmentUK Laboratories Performing Infectious Disease Tests Forecast by Market SegmentUK Hospital Laboratories Performing Infectious Disease Tests by Bed SizeUK Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test VolumeUK All Market Segments Infectious Disease Test Volume ForecastUK Hospital Laboratories Infectious Disease Test Volume ForecastUK Blood Banks Infectious Disease Test Volume ForecastUK Commercial/Private Laboratories Infectious Disease Test Volume ForecastUK All Market Segments Infectious Disease Diagnostics Market ForecastUK Hospital Laboratories Infectious Disease Diagnostics Market ForecastUK Blood Banks Infectious Disease Diagnostics Market ForecastUK Commercial/Private Laboratories Infectious DiseaseDiagnostics Market ForecastUK HIV or HIV I/HIVII Test Volume and Diagnostics Sales Forecast by Market SegmentUK HIV Ag Test Volume and Diagnostics Sales Forecast by Market SegmentUK Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by MarketSegmentUK Adenovirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Aeromonads Test Volume and Diagnostics Sales Forecast by Market SegmentUK BEA Test Volume and Diagnostics Sales Forecast by Market SegmentUK Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • 12. UK Campylobacter Test Volume and Diagnostics Sales Forecast by Market SegmentUK Candida Test Volume and Diagnostics Sales Forecast by Market SegmentUK Chancroid Test Volume and Diagnostics Sales Forecast by Market SegmentUK Chlamydia Test Volume and Diagnostics Sales Forecast by Market SegmentUK Clostridium Test Volume and Diagnostics Sales Forecast by Market SegmentUK CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market SegmentUK Cyclospora Test Volume and Diagnostics Sales Forecast by Market SegmentUK CMV Test Volume and Diagnostics Sales Forecast by Market SegmentUK E. Coli Test Volume and Diagnostics Sales Forecast by Market SegmentUK Echovirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Encephalitis Test Volume and Diagnostics Sales Forecast by Market SegmentUK Enterovirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK EBV Test Volume and Diagnostics Sales Forecast by Market SegmentUK Giardia Test Volume and Diagnostics Sales Forecast by Market SegmentUK Gonorrhea Test Volume and Diagnostics Sales Forecast by Market SegmentUK Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market SegmentUKHantavirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market SegmentUK HAV NAT Test Volume and Diagnostics Sales Forecast by Market SegmentUK HBV NAT Test Volume and Diagnostics Sales Forecast by Market SegmentUK HBsAg Test Volume and Diagnostics Sales Forecast by Market SegmentUK Hepatitis C Test Volume and Diagnostics Sales Forecast by Market SegmentUK Anti-HBc Test Volume and Diagnostics Sales Forecast by Market SegmentUK Anti-HBs Test Volume and Diagnostics Sales Forecast by Market SegmentUK Anti-HAV Test Volume and Diagnostics Sales Forecast by Market SegmentUK Hepatitis Delta Test Volume and Diagnostics SalesForecast by Market SegmentUK HBcAg Test Volume and Diagnostics Sales Forecast by Market SegmentUK HBeAg Test Volume and Diagnostics Sales Forecast by Market SegmentUK ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market SegmentUK Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market SegmentUK Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market SegmentUK HTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market SegmentUK Influenza Test Volume and Diagnostics Sales Forecast by Market SegmentUK Legionella Test Volume and Diagnostics Sales Forecast by Market SegmentUK Lyme Disease Test Volume and Diagnostics Sales Forecast by Market SegmentUK Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market SegmentUK Malaria Test Volume and Diagnostics Sales Forecast by Market SegmentUK Measles Test Volume and Diagnostics Sales Forecast by Market SegmentUK Meningitis Test Volume and Diagnostics Sales Forecast by Market SegmentUK Microsporidium Test Volume and Diagnostics Sales Forecast by Market SegmentUK Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • 13. UK Mumps Test Volume and Diagnostics Sales Forecast by Market SegmentUK Mycoplasma Test Volume and Diagnostics Sales Forecast by Market SegmentUK Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Parvovirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Pneumonia Test Volume and Diagnostics Sales Forecast by Market SegmentUK Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market SegmentUK Pseudomonas Test Volume and Diagnostics Sales Forecast by Market SegmentUK Rabies Test Volume and Diagnostics Sales Forecast by Market SegmentUK RSV Test Volume and Diagnostics Sales Forecast by Market SegmentUK Rhinovirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Rotavirus Test Volume and Diagnostics Sales Forecast by Market SegmentUK Rubella Test Volume and Diagnostics Sales Forecast by Market SegmentUK Salmonella Test Volume and Diagnostics Sales Forecast by Market SegmentUK Septicemia Test Volume and Diagnostics Sales Forecast by Market SegmentUK Shigella Test Volume and Diagnostics Sales Forecast by Market SegmentUK Staphylococci Test Volume and Diagnostics Sales Forecast by Market SegmentUK Streptococci Test Volume and Diagnostics Sales Forecast by Market SegmentUK Syphilis Test Volume and Diagnostics Sales Forecast by Market SegmentUK Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market SegmentUK Trichomonas Test Volume and Diagnostics Sales Forecast by Market SegmentUK Tuberculosis Test Volume and Diagnostics Sales Forecast by Market SegmentUK Vibrio Test Volume and Diagnostics Sales Forecast by Market SegmentUK West Nile Test Volume and Diagnostics Sales Forecast by Market SegmentUK Yersinia Test Volume and Diagnostics Sales Forecast by Market SegmentUK AIDS Testing Market Diagnostics Sales by Major SupplierList of Tables (continued)UK Campylobacter Testing Market Diagnostics Sales by Major SupplierUK Candida Testing Market Diagnostics Sales by Major SupplierUK CMV Testing Market Diagnostics Sales by Major SupplierUK EBV Testing Market Diagnostics Sales by Major SupplierUK Gonorrhea Testing Market Diagnostics Sales by Major SupplierUK Hepatitis Testing Market Diagnostics Sales by Major SupplierUK Hepatitis C Testing Market Diagnostics Sales by Major SupplierUK Herpes Testing Market Diagnostics Sales by Major SupplierUK Influenza Testing Market Diagnostics Sales by Major SupplierUK Legionella Testing Market Diagnostics Sales by Major SupplierUK Meningitis Testing Market Diagnostics Sales by Major SupplierUK Mononucleosis Testing Market Diagnostics Sales by Major SupplierUK Mycoplasma Testing Market Diagnostics Sales by Major SupplierUK Pneumonia Testing Market Diagnostics Sales by Major SupplierUK RSV Testing Market Diagnostics Sales Forecast by Major SupplierUK Rotavirus Testing Market Diagnostics Sales by Major SupplierUK Rubella Testing Market Diagnostics Sales by Major Supplier
  • 14. UK Septicemia Testing Market Diagnostics Sales by Major SupplierUK Streptococci Testing Market Diagnostics Sales by Major SupplierUK Toxoplasmosis Testing Market Diagnostics Sales by Major SupplierUK Trichomonas Testing Market Diagnostics Sales by Major SupplierUK Tuberculosis Testing Market Diagnostics Sales by Major SupplierContact: sales@reportsandreports.com for more information.